Article
Dysregulated immune microenvironment in metastatic colorectal cancer.
Medical oncology (Northwood, London, England) - 24 Feb 2026
An Shuaixing, Yu Zhaojin, Li Jianping, Wei Minjie
Abstract excerpt
Emerging evidence highlights that metastatic colorectal cancer (mCRC) can occur early in tumor progression, with its unique genomic characteristics contributing to an altered immune landscape. This study aims to elucidate the molecular and immune mechanisms that drive mCRC progression and therapeutic resistance. By leveraging multi-omics data, we examined immune infiltration, immune subtypes, tumor mutational...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
